Associate Professor, Division of General Medicine, Geriatrics, and Bioethics
To see if Stephen Gresham Henry is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
General Internal Medicine
4860 Y St.
Sacramento, CA 95817
Phone: 916-734-2737
My goal is to provide high-quality, non-judgmental care to patients.
Dr. Henry is a general internist who offers care to adults in both the inpatient and outpatient (primary care) settings. He has special clinical interests in chronic pain management.
Dr Henry's research interests include: patient-clinician communication; chronic pain management; primary care; controlled substance epidemiology; prescription drug monitoring programs; overdose prevention; patient experience.
A.B., Chemistry, Harvard University, Cambridge MA 2000
M.D., Vanderbilt University School of Medicine, Nashville TN 2006
M.Sc., Health and Healthcare, University of Michigan, Ann Arbor MI 2010
Internal Medicine, University of Michigan, Ann Arbor MI 2006-2009
RWJ Clinical Scholars Program, University of Michigan, Ann Arbor MI 2009-2012
Alpha Omega Alpha, 2005
https://pubmed.ncbi.nlm.nih.gov/?term=henry+sg&sort=date
Matthias MS, Henry SG. Reducing Frustration and Improving Management of Chronic Pain in Primary Care: Is Shared Decision-making Sufficient? J Gen Intern Med. 2022 Jan;37(1):227-228. doi:10.1007/s11606-021-06967-3. Epub 2021 Jun 25. PMID:34173195.
White AEC, Hood-Medland EA, Kravitz RL, Henry SG. Visit Linearity in Primary Care Visits for Patients with Chronic Pain on Long-term Opioid Therapy. J Gen Intern Med. 2022 Jan;37(1):78-86. doi:10.1007/s11606-021-06917-z. Epub 2021 Jun 22. PMID:34159543.
Henry SG, Shev AB, Crow D, Stewart SL, Wintemute GJ, Fenlon C, Wirtz SJ. Impacts of prescription drug monitoring program policy changes and county opioid safety coalitions on prescribing and overdose outcomes in California, 2015-2018. Prev Med. 2021 Dec;153:106861. doi:10.1016/j.ypmed.2021.106861. Epub 2021 Oct 20. PMID:34687731.
Tseregounis IE, Tancredi DJ, Stewart SL, Shev AB, Crawford A, Gasper JJ, Wintemute G, Marshall BDL, Cerdá M, Henry SG. A Risk Prediction Model for Long-term Prescription Opioid Use. Med Care. 2021 Dec 1;59(12):1051-1058. doi:10.1097/MLR.0000000000001651. PMID:34629423.
Henry SG, Stewart SL, Murphy E, Tseregounis IE, Crawford AJ, Shev AB, Gasper JJ, Tancredi DJ, Cerdá M, Marshall BDL, Wintemute GJ. Using Prescription Drug Monitoring Program Data to Assess Likelihood of Incident Long-Term Opioid Use: a Statewide Cohort Study. J Gen Intern Med. 2021 Dec;36(12):3672-3679. doi:10.1007/s11606-020-06555-x. Epub 2021 Mar 19. PMID:33742304.
Tseregounis IE, Henry SG. Assessing opioid overdose risk: a review of clinical prediction models utilizing patient-level data. Transl Res. 2021 Aug;234:74-87. doi:10.1016/j.trsl.2021.03.012. Epub 2021 Mar 21. PMID:33762186.
Fenton JJ, Magnan EM, Agnoli AL, Henry SG, Xing G, Tancredi DJ. Longitudinal Dose Trajectory Among Patients Tapering Long-Term Opioids. Pain Med. 2021 Jul 25;22(7):1660-1668. doi: 10.1093/pm/pnaa470. PMID: 33738505.
Henry SG, Feng B, Verba S, Kravitz RL, Iosif AM. The story vs the storyteller: Factors associated with the effectiveness of brief video-recorded patient stories for promoting opioid tapering. Health Expect. 2021 Jun;24(3):991-999. doi:10.1111/hex.13243. Epub 2021 Apr 9. PMID:33835644.
Castillo-Carniglia A, González-Santa Cruz A, Cerdá M, Delcher C, Shev AB, Wintemute GJ, Henry SG. Corrigendum to "Changes in opioid prescribing after implementation of mandatory registration and proactive reports within California's prescription drug monitoring program" [Drug Alcohol Depend. 218 (2021) 108405]. Drug Alcohol Depend. 2021 Apr 1;221:108606. doi:10.1016/j.drugalcdep.2021.108606. Epub 2021 Feb 18. Erratum for: Drug Alcohol Depend. 2021 Jan 1;218:108405. PMID:33611026.